Effects of Angiotensin II Type 1 Receptor Antagonist, YM358, on Cardiac Hypertrophy and Dysfunction after Myocardial Infarction in Rats

Tomoko Tokioka-Akagi; Akira Fujimori; Masayuki Shibasaki; Yasuko Matsuda-Satoh; Osamu Inagaki; Isao Yanagisawa

doi:10.1248/bpb.25.857

Effects of Angiotensin II Type 1 Receptor Antagonist, YM358, on Cardiac Hypertrophy and Dysfunction after Myocardial Infarction in Rats

Biological and Pharmaceutical Bulletin ◽

10.1248/bpb.25.857 ◽

2002 ◽

Vol 25 (7) ◽

pp. 857-860 ◽

Cited By ~ 5

Author(s):

Tomoko Tokioka-Akagi ◽

Akira Fujimori ◽

Masayuki Shibasaki ◽

Yasuko Matsuda-Satoh ◽

Osamu Inagaki ◽

...

Keyword(s):

Myocardial Infarction ◽

Angiotensin Ii ◽

Cardiac Hypertrophy ◽

Receptor Antagonist

Download Full-text

Inhibitory Effects of a Subdepressor Dose of L-158,809, an Angiotensin II Type 1 Receptor Antagonist, on Cardiac Hypertrophy and Nephropathy Via the Activated Human Renin-Angiotensin System in Double Transgenic Mice With Hypertension

Japanese Circulation Journal ◽

10.1253/jcj.62.599 ◽

1998 ◽

Vol 62 (8) ◽

pp. 599-603 ◽

Cited By ~ 10

Author(s):

Tatsuya Kai ◽

Keiichi Sugimura ◽

Seijiro Shimada ◽

Atsuhiro Kurooka ◽

Toshihiko Takenaka ◽

...

Keyword(s):

Angiotensin Ii ◽

Transgenic Mice ◽

Cardiac Hypertrophy ◽

Receptor Antagonist ◽

Renin Angiotensin System ◽

Inhibitory Effects ◽

Angiotensin System ◽

Human Renin ◽

Double Transgenic Mice

Download Full-text

Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction

Journal of Molecular and Cellular Cardiology ◽

10.1016/0022-2828(95)90013-6 ◽

1995 ◽

Vol 27 (9) ◽

pp. 1905-1914 ◽

Cited By ~ 64

Author(s):

A Hanatani

Keyword(s):

Myocardial Infarction ◽

Angiotensin Ii ◽

Receptor Antagonist ◽

Phenotypic Modulation

Download Full-text

Angiotensin II Receptor Antagonist, E-4177, Inhibits Progression of Reactive Cardiac Hypertrophy Associated with Myocardial Infarction in Rats

Developments in Cardiovascular Medicine - Mechanisms of Heart Failure ◽

10.1007/978-1-4615-2003-0_34 ◽

1995 ◽

pp. 387-400

Author(s):

Tomoji Hata ◽

Naoki Makino ◽

Ian M. C. Dixon ◽

Masahiko Nozaki ◽

Kazuhiro Masutomo ◽

...

Keyword(s):

Myocardial Infarction ◽

Angiotensin Ii ◽

Cardiac Hypertrophy ◽

Receptor Antagonist ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist

Download Full-text

A Newly Developed Angiotensin II Type 1 Receptor Antagonist, CS866, Promotes Regression of Cardiac Hypertrophy by Reducing Integrin .BETA.1 Expression

Hypertension Research ◽

10.1291/hypres.26.737 ◽

2003 ◽

Vol 26 (9) ◽

pp. 737-742 ◽

Cited By ~ 17

Author(s):

Nan JIA ◽

Hiroshi OKAMOTO ◽

Toshihiro SHIMIZU ◽

Satoru CHIBA ◽

Yutaka MATSUI ◽

...

Keyword(s):

Angiotensin Ii ◽

Cardiac Hypertrophy ◽

Receptor Antagonist ◽

Regression Of Cardiac Hypertrophy

Download Full-text

Angiotensin II type 1 receptor antagonist candesartan cilexitil prevents left ventricular systolic and diastolic dysfunction after myocardial infarction

Journal of Cardiac Failure ◽

10.1016/s1071-9164(98)90344-x ◽

1998 ◽

Vol 4 (3) ◽

pp. 78

Author(s):

Akihisa Hanatani ◽

Minoru Yoshiyama ◽

Kazuhide Takeuchi ◽

Takashi Omura ◽

Hiroyuki Yamagishi ◽

...

Keyword(s):

Myocardial Infarction ◽

Angiotensin Ii ◽

Diastolic Dysfunction ◽

Receptor Antagonist ◽

Left Ventricular

Download Full-text

Additive improvement of left ventricular remodeling by aldosterone receptor blockade with eplerenone and angiotensin II type 1 receptor antagonist in rats with myocardial infarction

Folia Pharmacologica Japonica ◽

10.1254/fpj.124.83 ◽

2004 ◽

Vol 124 (2) ◽

pp. 83-89 ◽

Cited By ~ 4

Author(s):

Minoru YOSHIYAMA ◽

Takashi OMURA ◽

Jyunichi YOSHIKAWA

Keyword(s):

Myocardial Infarction ◽

Angiotensin Ii ◽

Receptor Antagonist ◽

Ventricular Remodeling ◽

Left Ventricular Remodeling ◽

Left Ventricular ◽

Receptor Blockade ◽

Aldosterone Receptor

Download Full-text

Angiotensin II type 1-receptor antagonist telmisartan prevents left ventricular remodeling after myocardial infarction

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2004.08.109 ◽

2004 ◽

Vol 10 (5) ◽

pp. S182

Author(s):

Onai Yasuyuki ◽

Suzuki Jun-Ichi ◽

Gotoh Ryo ◽

Isobe Mitsuaki

Keyword(s):

Myocardial Infarction ◽

Angiotensin Ii ◽

Receptor Antagonist ◽

Ventricular Remodeling ◽

Left Ventricular Remodeling ◽

Left Ventricular

Download Full-text

Faculty Opinions recommendation of An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1047225.497149 ◽

2006 ◽

Author(s):

Søren Sheikh

Keyword(s):

Epidermal Growth Factor Receptor ◽

Angiotensin Ii ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cardiac Hypertrophy ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Receptor Mutant ◽

Receptor Transactivation

Download Full-text

Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer

Human Cell ◽

10.1111/j.1749-0774.2007.00025.x ◽

2007 ◽

Vol 20 (1) ◽

pp. 1-9 ◽

Cited By ~ 23

Author(s):

Michio KOSUGI ◽

Akira MIYAJIMA ◽

Eiji KIKUCHI ◽

Takeo KOSAKA ◽

Yutaka HORIGUCHI ◽

...

Keyword(s):

Bladder Cancer ◽

Angiotensin Ii ◽

Tumor Growth ◽

Receptor Antagonist ◽

Xenograft Model ◽

Human Bladder Cancer ◽

Human Bladder

Download Full-text

Long-term treatment with angiotensin II type 1 receptor antagonist, CV-11974, restores β-catenin mRNA expression in volume-overloaded rabbit hearts

Heart and Vessels ◽

10.1007/s003800200040 ◽

2002 ◽

Vol 17 (1) ◽

pp. 36-41 ◽

Cited By ~ 8

Author(s):

Makoto Itoh ◽

Y. Takeishi ◽

Shigekazu Nakada ◽

Takuya Miyamoto ◽

Yuichi Tsunoda ◽

...

Keyword(s):

Angiotensin Ii ◽

Receptor Antagonist ◽

Mrna Expression ◽

Term Treatment ◽

Long Term Treatment

Download Full-text